{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:13:21Z","timestamp":1761808401560,"version":"build-2065373602"},"reference-count":186,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012411","name":"Alborz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.intimp.2020.107082","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T11:33:59Z","timestamp":1602329639000},"page":"107082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"PB","title":["Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics"],"prefix":"10.1016","volume":"89","author":[{"given":"Negin","family":"Ebrahimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Aslani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Babaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Hemmatzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab","family":"Joneidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Mehdizadeh Tourzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nafiseh","family":"Pakravan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2020.107082_b0005","first-page":"988345","article-title":"SARS-CoV-2 invades host cells via a novel route: CD147-spike protein","author":"Wang","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.intimp.2020.107082_b0010","first-page":"20030650","article-title":"Immunodepletion with hypoxemia: a potential high risk subtype of coronavirus disease 2019","author":"Yu","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.intimp.2020.107082_b0015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev.pathmechdis.3.121806.154316","article-title":"The pathology of influenza virus infections","volume":"3","author":"Taubenberger","year":"2008","journal-title":"Ann. Rev. Pathol."},{"key":"10.1016\/j.intimp.2020.107082_b0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cyto.2018.01.025","article-title":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","volume":"104","author":"Mahallawi","year":"2018","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.intimp.2020.107082_b0025","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41418-020-0530-3","article-title":"COVID-19 infection: the perspectives on immune responses","volume":"27","author":"Shi","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2020.107082_b0030","first-page":"20034736","article-title":"Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China","author":"Shi","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.intimp.2020.107082_b0035","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.intimp.2020.107082_b0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fmolb.2020.00157","article-title":"Immune phenotyping based on the neutrophil-to-lymphocyte ratio and IgG level predicts disease severity and outcome for patients with COVID-19","volume":"7","author":"Zhang","year":"2020","journal-title":"Front. Mole. Biosci."},{"key":"10.1016\/j.intimp.2020.107082_b0045","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6915e3","article-title":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019\u2014COVID-NET, 14 States, March 1\u201330, 2020","volume":"69","author":"Garg","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.intimp.2020.107082_b0050","first-page":"91","article-title":"Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: a systematic review and meta-analysis","volume":"94","author":"Yanga","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.intimp.2020.107082_b0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m1198","article-title":"Covid-19: risk factors for severe disease and death","author":"Jordan","year":"2020","journal-title":"British Med. J. Publ. Group"},{"key":"10.1016\/j.intimp.2020.107082_b0060","article-title":"The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: a systematic review and meta-analysis","author":"Matsushita","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.intimp.2020.107082_b0065","article-title":"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients","author":"Williamson","year":"2020","journal-title":"MedRxiv"},{"issue":"6","key":"10.1016\/j.intimp.2020.107082_b0070","doi-asserted-by":"crossref","first-page":"e0235248","DOI":"10.1371\/journal.pone.0235248","article-title":"Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens","volume":"15","author":"Bravi","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2020.107082_b0075","doi-asserted-by":"crossref","DOI":"10.2337\/dc20-1333","article-title":"Computed tomography highlights increased visceral adiposity associated with critical illness in COVID-19","author":"Battisti","year":"2020","journal-title":"Diab. Care"},{"issue":"5","key":"10.1016\/j.intimp.2020.107082_b0080","doi-asserted-by":"crossref","first-page":"e0233147","DOI":"10.1371\/journal.pone.0233147","article-title":"Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis","volume":"15","author":"Alqahtani","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2020.107082_b0085","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin\u2013angiotensin\u2013aldosterone system blockers and the risk of Covid-19","author":"Mancia","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2020.107082_b0090","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.intimp.2020.107082_b0095","article-title":"The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells","author":"Hoffmann","year":"2020","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.intimp.2020.107082_b0100","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2020.107082_b0105","first-page":"990770","article-title":"Potent human neutralizing antibodies elicited by SARS-CoV-2 infection","author":"Ju","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.intimp.2020.107082_b0110","first-page":"20045427","article-title":"The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes","author":"Chen","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.intimp.2020.107082_b0115","article-title":"The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike","author":"Li","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.intimp.2020.107082_b0120","doi-asserted-by":"crossref","first-page":"107503","DOI":"10.1016\/j.pharmthera.2020.107503","article-title":"Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions","volume":"209","author":"Shao","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/v11010059","article-title":"From SARS to MERS, thrusting coronaviruses into the spotlight","volume":"11","author":"Song","year":"2019","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.intimp.2020.107082_b0130","doi-asserted-by":"crossref","first-page":"L834","DOI":"10.1152\/ajplung.00031.2018","article-title":"DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice","volume":"315","author":"Kawasaki","year":"2018","journal-title":"Am. J. Physiol.-Lung Cell. Mole. Physiol."},{"key":"10.1016\/j.intimp.2020.107082_b0135","doi-asserted-by":"crossref","first-page":"e3330","DOI":"10.1002\/dmrr.3330","article-title":"DPP4 inhibition: preventing SARS-CoV-2 infection and\/or progression of COVID-19?","author":"Strollo","year":"2020","journal-title":"Diab.\/metabolism Res. Rev."},{"issue":"6","key":"10.1016\/j.intimp.2020.107082_b0140","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2020.107082_b0145","doi-asserted-by":"crossref","first-page":"e33213321","DOI":"10.1002\/dmrr.3321","article-title":"Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics","author":"Maddaloni","year":"2020","journal-title":"Diab.\/metabolism Res. Rev."},{"issue":"7","key":"10.1016\/j.intimp.2020.107082_b0150","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.humimm.2009.05.006","article-title":"Association of human leukocyte antigen class II alleles with severe acute respiratory syndrome in the Vietnamese population","volume":"70","author":"Keicho","year":"2009","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107082_b0155","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/JCM.44.2.359-365.2006","article-title":"Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003","volume":"44","author":"Chen","year":"2006","journal-title":"J. Clin. Microbiol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107082_b0160","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/vim.2011.0024","article-title":"Human-leukocyte antigen class I Cw 1502 and class II DR 0301 genotypes are associated with resistance to severe acute respiratory syndrome (SARS) infection","volume":"24","author":"Wang","year":"2011","journal-title":"Viral Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107082_b0165","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1164\/rccm.202001-0179LE","article-title":"Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2","volume":"202","author":"Zhao","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.intimp.2020.107082_b0170","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2020.107082_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2020.04.009","article-title":"Blockade of SARS-CoV-2 infection by recombinant soluble ACE2","author":"Alhenc-Gelas","year":"2020","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.intimp.2020.107082_b0180","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus infections and immune responses","volume":"92","author":"Li","year":"2020","journal-title":"J. Med. Virol."},{"issue":"9","key":"10.1016\/j.intimp.2020.107082_b0185","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nri888","article-title":"Viruses and interferon: a fight for supremacy","volume":"2","author":"Katze","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2020.107082_b0190","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3389\/fimmu.2016.00498","article-title":"Viral evasion strategies in type I IFN signaling \u2013 a summary of recent developments","volume":"7","author":"Schulz","year":"2016","journal-title":"Front. Immunol."},{"issue":"Pt 1","key":"10.1016\/j.intimp.2020.107082_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.18709-0","article-title":"Virus complement evasion strategies","volume":"84","author":"Favoreel","year":"2003","journal-title":"J. Gen. Virol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107082_b0200","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF02970145","article-title":"Viral mimicry of the complement system","volume":"28","author":"Bernet","year":"2003","journal-title":"J. Biosci."},{"issue":"5","key":"10.1016\/j.intimp.2020.107082_b0205","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1634\/stemcells.2005-0173","article-title":"Multilevel regulation of IL-6R by IL-6-sIL-6R fusion protein according to the primitiveness of peripheral blood-derived CD133+ cells","volume":"24","author":"Campard","year":"2006","journal-title":"Stem cells (Dayton, Ohio)"},{"issue":"7","key":"10.1016\/j.intimp.2020.107082_b0210","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.201040391","article-title":"IL-6: regulator of Treg\/Th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"7090","key":"10.1016\/j.intimp.2020.107082_b0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2020.107082_b0220","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat. Immunol."},{"issue":"4\u20135","key":"10.1016\/j.intimp.2020.107082_b0225","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.micinf.2020.04.005","article-title":"The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement","volume":"22","author":"Hotez","year":"2020","journal-title":"Microbes Infect."},{"key":"10.1016\/j.intimp.2020.107082_b0230","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","author":"Xu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"10229","key":"10.1016\/j.intimp.2020.107082_b0235","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2020.107082_b0240","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit. Care Med."},{"issue":"3","key":"10.1016\/j.intimp.2020.107082_b0245","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00281-004-0180-4","article-title":"Plasmacytoid dendritic cell precursors\/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9","volume":"26","author":"Ito","year":"2005","journal-title":"Springer Semin. Immunopathol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0250","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.virusres.2007.03.015","article-title":"SARS coronavirus and innate immunity","volume":"133","author":"Frieman","year":"2008","journal-title":"Virus Res."},{"issue":"11","key":"10.1016\/j.intimp.2020.107082_b0255","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1128\/JVI.02199-05","article-title":"Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha\/beta interferon production induced by RIG-I signaling","volume":"80","author":"Cardenas","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2020.107082_b0260","article-title":"Impaired interferon signature in severe COVID-19","volume":"1","author":"Gruber","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107082_b0265","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jmv.20255","article-title":"An interferon-gamma-related cytokine storm in SARS patients","volume":"75","author":"Huang","year":"2005","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.intimp.2020.107082_b0270","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Yao","year":"2020","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.intimp.2020.107082_b0275","doi-asserted-by":"crossref","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"10","key":"10.1016\/j.intimp.2020.107082_b0280","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"10.1016\/j.intimp.2020.107082_b0285","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3389\/fmicb.2017.01117","article-title":"Complement evasion strategies of viruses: an overview","volume":"8","author":"Agrawal","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2020.107082_b0290","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.3389\/fimmu.2018.03125","article-title":"Complement activation as a helping hand for inflammophilic pathogens and cancer","volume":"9","author":"Okroj","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0295","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00281-017-0644-y","article-title":"Complement as a regulator of adaptive immunity","volume":"40","author":"Killick","year":"2018","journal-title":"Semin Immunopathol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107082_b0300","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01753-18","article-title":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","volume":"9","author":"Gralinski","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.intimp.2020.107082_b0305","first-page":"20041962","article-title":"Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation","author":"Gao","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.intimp.2020.107082_b0310","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fimmu.2015.00215","article-title":"Complement-coagulation cross-talk: a potential mediator of the physiological activation of complement by low pH","volume":"6","author":"Kenawy","year":"2015","journal-title":"Front. Immunol."},{"issue":"Suppl 1(0 1)","key":"10.1016\/j.intimp.2020.107082_b0315","article-title":"Crosstalk between the coagulation and complement systems in sepsis","volume":"133","author":"Lupu","year":"2014","journal-title":"Thrombosis Res."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0320","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cyto.2011.01.007","article-title":"IL-6 plays an essential role in neutrophilia under inflammation","volume":"54","author":"Hashizume","year":"2011","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.intimp.2020.107082_b0325","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1084\/jem.20110919","article-title":"Regulation of neutrophils by interferon-gamma limits lung inflammation during tuberculosis infection","volume":"208","author":"Nandi","year":"2011","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.intimp.2020.107082_b0330","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2020.107082_b0335","first-page":"104370","article-title":"Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19, Journal of clinical virology: the official publication of the Pan American Society for Clinical","volume":"127","author":"Liu","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.intimp.2020.107082_b0340","doi-asserted-by":"crossref","first-page":"102437","DOI":"10.1016\/j.bcmd.2020.102437","article-title":"Increased expression of CD8 marker on T-cells in COVID-19 patients","volume":"83","author":"Ganji","year":"2020","journal-title":"Blood Cells Mol. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0345","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1038\/s41467-020-17240-2","article-title":"Immunological and inflammatory profiles in mild and severe cases of COVID-19","volume":"11","author":"Song","year":"2020","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.intimp.2020.107082_b0350","first-page":"e23","article-title":"Understanding the T cell immune response in SARS coronavirus infection","volume":"1","author":"Janice Oh","year":"2012","journal-title":"Emerg. Microbes Infect."},{"issue":"6","key":"10.1016\/j.intimp.2020.107082_b0355","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/cid\/ciy595","article-title":"Immune responses to middle east respiratory syndrome coronavirus during the acute and convalescent phases of human infection","volume":"68","author":"Shin","year":"2019","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"issue":"12","key":"10.1016\/j.intimp.2020.107082_b0360","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1371\/journal.pmed.0030525","article-title":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants","volume":"3","author":"Deming","year":"2006","journal-title":"PLoS Med."},{"issue":"9","key":"10.1016\/j.intimp.2020.107082_b0365","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.4049\/jimmunol.181.9.6337","article-title":"Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV","volume":"181","author":"Yasui","year":"2008","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107082_b0370","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.virol.2006.06.011","article-title":"Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells","volume":"353","author":"de Lang","year":"2006","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.intimp.2020.107082_b0375","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.coph.2006.03.001","article-title":"Angiotensin-converting enzyme 2 in lung diseases","volume":"6","author":"Kuba","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.intimp.2020.107082_b0380","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"issue":"827","key":"10.1016\/j.intimp.2020.107082_b0385","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107082_b0390","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ni757","article-title":"CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses","volume":"3","author":"Moser","year":"2002","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0395","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s40425-019-0761-3","article-title":"Monalizumab: inhibiting the novel immune checkpoint NKG2A","volume":"7","author":"van Hall","year":"2019","journal-title":"J. ImmunoTher. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0400","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1084\/jem.20081571","article-title":"The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells","volume":"206","author":"Dienz","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2020.107082_b0405","doi-asserted-by":"crossref","first-page":"102452","DOI":"10.1016\/j.jaut.2020.102452","article-title":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","volume":"111","author":"Liu","year":"2020","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.20499","article-title":"Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals","volume":"78","author":"Zhang","year":"2006","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.intimp.2020.107082_b0415","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0420","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/s41467-020-16048-4","article-title":"Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig","volume":"11","author":"Lei","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0425","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","article-title":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody","volume":"9","author":"Tian","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0430","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/s41467-020-16256-y","article-title":"A human monoclonal antibody blocking SARS-CoV-2 infection","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2020.107082_b0435","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2020.107082_b0440","doi-asserted-by":"crossref","first-page":"102768","DOI":"10.1016\/j.ebiom.2020.102768","article-title":"Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development","volume":"55","author":"de Alwis","year":"2020","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.intimp.2020.107082_b0445","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI138745","article-title":"Deployment of convalescent plasma for the prevention and treatment of COVID-19","volume":"130","author":"Bloch","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.intimp.2020.107082_b0450","doi-asserted-by":"crossref","first-page":"107725","DOI":"10.1016\/j.celrep.2020.107725","article-title":"Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections","volume":"31","author":"Lv","year":"2020","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.intimp.2020.107082_b0455","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200678","article-title":"The many faces of the anti-COVID immune response","volume":"217","author":"Vardhana","year":"2020","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.intimp.2020.107082_b0460","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1084\/jem.20151267","article-title":"The role of Fc-FcgammaR interactions in IgG-mediated microbial neutralization","volume":"212","author":"Bournazos","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2020.107082_b0465","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.intimp.2020.107082_b0470","doi-asserted-by":"crossref","first-page":"e13304","DOI":"10.1111\/aji.13304","article-title":"COVID-19 and Treg\/Th17 imbalance: potential relationship to pregnancy outcomes","author":"Muyayalo","year":"2020","journal-title":"Am. J. Reprod. Immunol. (New York, N.Y.: 1989)"},{"issue":"5","key":"10.1016\/j.intimp.2020.107082_b0475","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/bjh.16690","article-title":"Reactive lymphocytes in patients with COVID-19","volume":"189","author":"Chong","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0480","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","article-title":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","volume":"12","author":"Xu","year":"2020","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.intimp.2020.107082_b0485","first-page":"20031120","article-title":"Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection","author":"Diao","year":"2020","journal-title":"medRxiv"},{"issue":"8","key":"10.1016\/j.intimp.2020.107082_b0490","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.4049\/jimmunol.169.8.4288","article-title":"IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha","volume":"169","author":"Liao","year":"2002","journal-title":"J. Immunol. (Baltimore, Md. 1950)"},{"issue":"9","key":"10.1016\/j.intimp.2020.107082_b0495","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0500","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12967-020-02374-0","article-title":"Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage","volume":"18","author":"Liu","year":"2020","journal-title":"J. Transl. Med."},{"issue":"10229","key":"10.1016\/j.intimp.2020.107082_b0505","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2020.107082_b0510","first-page":"945576","article-title":"Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus","author":"Zhou","year":"2020","journal-title":"BioRxiv"},{"issue":"4","key":"10.1016\/j.intimp.2020.107082_b0515","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"The Lancet. Respiratory Med."},{"key":"10.1016\/j.intimp.2020.107082_b0520","unstructured":"F.A. Lagunas-Rangel, Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis, J. Med. Virol."},{"key":"10.1016\/j.intimp.2020.107082_b0525","first-page":"20031906","article-title":"COVID-19 early warning score: a multi-parameter screening tool to identify highly suspected patients","author":"Song","year":"2020","journal-title":"medRxiv"},{"issue":"7","key":"10.1016\/j.intimp.2020.107082_b0530","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","article-title":"A single-cell atlas of the peripheral immune response in patients with severe COVID-19","volume":"26","author":"Wilk","year":"2020","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.intimp.2020.107082_b0535","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41423-020-0401-3","article-title":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2020.107082_b0540","first-page":"20089300","article-title":"Functional alteration of innate T cells in critically ill Covid-19 patients","author":"Jouan","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.intimp.2020.107082_b0545","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.intimp.2020.107082_b0550","doi-asserted-by":"crossref","first-page":"108393","DOI":"10.1016\/j.clim.2020.108393","article-title":"The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China","volume":"214","author":"Zhang","year":"2020","journal-title":"Clin. Immunol. (Orlando, Fla.)"},{"key":"10.1016\/j.intimp.2020.107082_b0555","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","author":"Guo","year":"2020","journal-title":"JAMA Cardiol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107082_b0560","first-page":"242","article-title":"Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction","volume":"8","author":"Ten","year":"2002","journal-title":"Curr. Opin. Crit. Care"},{"issue":"5","key":"10.1016\/j.intimp.2020.107082_b0565","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.intimp.2020.107082_b0570","first-page":"20097394","article-title":"Outbreak of Kawasaki disease in children during COVID-19 pandemic: a prospective observational study in Paris, France","author":"Toubiana","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.intimp.2020.107082_b0575","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.120.048360","article-title":"Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic","author":"Belhadjer","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2020.107082_b0580","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)31103-X","article-title":"An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study","author":"Verdoni","year":"2020","journal-title":"Lancet"},{"issue":"10237","key":"10.1016\/j.intimp.2020.107082_b0585","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2020.107082_b0590","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2020-322294","article-title":"Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19","author":"Zuo","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2020.107082_b0595","article-title":"Gut microbiota and COVID-19: a superfluous diagnostic biomarker or therapeutic target?","author":"Klann","year":"2020","journal-title":"Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am."},{"issue":"2","key":"10.1016\/j.intimp.2020.107082_b0600","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol.: J. Pathol. Soc. Great Britain Ireland"},{"key":"10.1016\/j.intimp.2020.107082_b0605","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fimmu.2018.00182","article-title":"Respiratory disease following viral lung infection alters the murine gut microbiota","volume":"9","author":"Groves","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0610","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00018-017-2671-1","article-title":"Role of gut microbiota in aging-related health decline: insights from invertebrate models","volume":"75","author":"Clark","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2020.107082_b0615","article-title":"Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients","author":"Liu","year":"2020","journal-title":"J. Infect."},{"issue":"27","key":"10.1016\/j.intimp.2020.107082_b0620","doi-asserted-by":"crossref","first-page":"12204","DOI":"10.1073\/pnas.0909122107","article-title":"Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota","volume":"107","author":"Round","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2020.107082_b0625","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.alit.2017.08.001","article-title":"Bugging allergy; role of pre-, pro-and synbiotics in allergy prevention","volume":"66","author":"West","year":"2017","journal-title":"Allergol. Int."},{"issue":"4","key":"10.1016\/j.intimp.2020.107082_b0630","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2222.2006.02629.x","article-title":"Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma","volume":"37","author":"Feleszko","year":"2007","journal-title":"Clin. Exp. Allergy"},{"issue":"3","key":"10.1016\/j.intimp.2020.107082_b0635","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/jir.2014.0038","article-title":"Hydroxychloroquine-inhibited dengue virus is associated with host defense machinery","volume":"35","author":"Wang","year":"2015","journal-title":"J. Interferon Cytokine Res.: Off. J. Int. Soc. Interferon Cytokine Res."},{"issue":"2","key":"10.1016\/j.intimp.2020.107082_b0640","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0042-6822(90)90099-D","article-title":"Acidotropic amines inhibit proteolytic processing of flavivirus prM protein","volume":"174","author":"Randolph","year":"1990","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0645","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"4","key":"10.1016\/j.intimp.2020.107082_b0650","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.medmal.2020.03.006","article-title":"No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection","volume":"50","author":"Molina","year":"2020","journal-title":"Medecine et maladies infectieuses"},{"issue":"2","key":"10.1016\/j.intimp.2020.107082_b0655","first-page":"215","article-title":"[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19], Zhejiang da xue xue bao","volume":"49","author":"Chen","year":"2020","journal-title":"Yi xue ban = J. Zhejiang Univ. Med. Sci."},{"key":"10.1016\/j.intimp.2020.107082_b0660","first-page":"m1849","article-title":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial","volume":"369","author":"Tang","year":"2020","journal-title":"BMJ (Clin. Res. Ed.)"},{"issue":"6","key":"10.1016\/j.intimp.2020.107082_b0665","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJMoa2016638","article-title":"A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19","volume":"383","author":"Boulware","year":"2020","journal-title":"New Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0670","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1186\/s13063-020-04659-7","article-title":"Hydroxychloroquine for post-exposure prophylaxis of COVID-19 among naval personnel in Sri Lanka: study protocol for a randomized, controlled trial","volume":"21","author":"Niriella","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.intimp.2020.107082_b0675","doi-asserted-by":"crossref","DOI":"10.1038\/s41564-020-0769-y","article-title":"LY6E impairs coronavirus fusion and confers immune control of viral disease","author":"Pfaender","year":"2020","journal-title":"Nat. Microbial."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0680","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13054-020-02942-2","article-title":"Age and sex differences in soluble ACE2 may give insights for COVID-19","volume":"24","author":"Sw\u00e4rd","year":"2020","journal-title":"Critical Care (Lond. Engl.)"},{"key":"10.1016\/j.intimp.2020.107082_b0685","doi-asserted-by":"crossref","first-page":"104899","DOI":"10.1016\/j.phrs.2020.104899","article-title":"Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: clinical outcome and differences in post-treatment hospitalisation status","volume":"158","author":"Antinori","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"10236","key":"10.1016\/j.intimp.2020.107082_b0690","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet (Lond. Engl.)"},{"issue":"2","key":"10.1016\/j.intimp.2020.107082_b0695","doi-asserted-by":"crossref","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.intimp.2020.107082_b0700","first-page":"E005","article-title":"Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies","volume":"36","author":"Chen","year":"2020","journal-title":"Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chin. J. Burns"},{"key":"10.1016\/j.intimp.2020.107082_b0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2020.03.012","article-title":"COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal","volume":"39","author":"Siddiqi","year":"2020","journal-title":"J. Heart Lung Transplant."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0710","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1186\/s13054-020-03224-7","article-title":"Efficacy of tocilizumab treatment in severely ill COVID-19 patients","volume":"24","author":"Zhao","year":"2020","journal-title":"Critical Care (Lond. Engl.)"},{"issue":"2","key":"10.1016\/j.intimp.2020.107082_b0715","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jinf.2004.09.008","article-title":"The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study","volume":"51","author":"Auyeung","year":"2005","journal-title":"J. Infect."},{"issue":"12","key":"10.1016\/j.intimp.2020.107082_b0720","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1164\/rccm.200306-766OC","article-title":"High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome","volume":"168","author":"Ho","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0725","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jinf.2006.01.005","article-title":"Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong","volume":"54","author":"Yam","year":"2007","journal-title":"J. Infect."},{"issue":"3","key":"10.1016\/j.intimp.2020.107082_b0730","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0735","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11239-020-02138-z","article-title":"Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum","volume":"50","author":"Barnes","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"issue":"10229","key":"10.1016\/j.intimp.2020.107082_b0740","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.intimp.2020.107082_b0745","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41585-020-0325-9","article-title":"Could BCG be used to protect against COVID-19?","volume":"17","author":"Redelman-Sidi","year":"2020","journal-title":"Nat. Rev. Urol."},{"issue":"6","key":"10.1016\/j.intimp.2020.107082_b0750","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","article-title":"BCG-induced trained immunity: can it offer protection against COVID-19?","volume":"20","author":"O\u2019Neill","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2020.107082_b0755","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)31025-4","article-title":"Considering BCG vaccination to reduce the impact of COVID-19","author":"Curtis","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2020.107082_b0760","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.8189","article-title":"SARS-CoV-2 rates in BCG-vaccinated and unvaccinated young adults","author":"Hamiel","year":"2020","journal-title":"JAMA"},{"issue":"6284","key":"10.1016\/j.intimp.2020.107082_b0765","doi-asserted-by":"crossref","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science (New York, N.Y.)"},{"issue":"2","key":"10.1016\/j.intimp.2020.107082_b0770","doi-asserted-by":"crossref","first-page":"462","DOI":"10.14336\/AD.2020.0301","article-title":"Mesenchymal stem cell infusion shows promise for combating Coronavirus (COVID-19)-induced pneumonia","volume":"11","author":"Shetty","year":"2020","journal-title":"Aging Dis."},{"issue":"11","key":"10.1016\/j.intimp.2020.107082_b0775","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni.3002","article-title":"Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications","volume":"15","author":"Wang","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2020.107082_b0780","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.matbio.2018.06.006","article-title":"Defective lung function following influenza virus is due to prolonged, reversible hyaluronan synthesis","volume":"80","author":"Bell","year":"2019","journal-title":"Matrix Biol.: J. Int. Soc. Matrix Biol."},{"issue":"48","key":"10.1016\/j.intimp.2020.107082_b0785","doi-asserted-by":"crossref","first-page":"eabd0110","DOI":"10.1126\/sciimmunol.abd0110","article-title":"Inhibition of Bruton tyrosine kinase in patients with severe COVID-19","volume":"5","author":"Roschewski","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.intimp.2020.107082_b0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytogfr.2020.06.008","article-title":"IL-15 immunotherapy is a viable strategy for COVID-19","author":"Kandikattu","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2020.107082_b0795","doi-asserted-by":"crossref","DOI":"10.1111\/1440-1681.13354","article-title":"A role for retinoids in the treatment of COVID-19?","author":"Trasino","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107082_b0800","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1172\/JCI111465","article-title":"1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells","volume":"74","author":"Lemire","year":"1984","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.intimp.2020.107082_b0805","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/1043-4666(92)90012-G","article-title":"1,25-dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level","volume":"4","author":"M\u00fcller","year":"1992","journal-title":"Cytokine"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2020.107082_b0810","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jsbmb.2005.06.002","article-title":"Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts","volume":"97","author":"van Etten","year":"2005","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0815","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1172\/JCI1050","article-title":"Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene","volume":"101","author":"D'Ambrosio","year":"1998","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0820","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/infdis\/jiq008","article-title":"1,25-dihydroxyvitamin D3 modulates cytokine production induced by Candida albicans: impact of seasonal variation of immune responses","volume":"203","author":"Khoo","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2020.107082_b0825","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/B978-0-12-386960-9.00005-8","article-title":"Vitamin A and retinoic acid in the regulation of B-cell development and antibody production","volume":"86","author":"Ross","year":"2011","journal-title":"Vitam. Horm."},{"issue":"9","key":"10.1016\/j.intimp.2020.107082_b0830","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nri2378","article-title":"Vitamin effects on the immune system: vitamins A and D take centre stage","volume":"8","author":"Mora","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2020.107082_b0835","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s12031-015-0643-1","article-title":"Molecular mechanisms of the action of vitamin A in Th17\/Treg axis in multiple sclerosis","volume":"57","author":"Abdolahi","year":"2015","journal-title":"J. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.intimp.2020.107082_b0840","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10067-016-3197-x","article-title":"Vitamin A improve Th17 and Treg regulation in systemic lupus erythematosus","volume":"35","author":"Handono","year":"2016","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0845","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.0105-2896.2005.00274.x","article-title":"Vitamin E and immune response in the aged: molecular mechanisms and clinical implications","volume":"205","author":"Meydani","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2020.107082_b0850","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/ajcn\/52.3.557","article-title":"Vitamin E supplementation enhances cell-mediated immunity in healthy elderly","volume":"52","author":"Meydani","year":"1990","journal-title":"Am. J. Clin. Nutrit."},{"key":"10.1016\/j.intimp.2020.107082_b0855","article-title":"Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data","volume":"356","author":"Martineau","year":"2017","journal-title":"BMJ (Clin. Res. Ed.)"},{"issue":"2","key":"10.1016\/j.intimp.2020.107082_b0860","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12020-020-02407-0","article-title":"The D-side of COVID-19: musculoskeletal benefits of vitamin D and beyond","volume":"69","author":"Tramontana","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.intimp.2020.107082_b0865","first-page":"20034447","article-title":"Potential biochemical markers to identify severe cases among COVID-19 patients","author":"Xiang","year":"2020","journal-title":"MedRxiv"},{"issue":"11","key":"10.1016\/j.intimp.2020.107082_b0870","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.intimp.2020.107082_b0875","first-page":"20030957","article-title":"Clinical features and outcomes of 2019 novel coronavirus-infected patients with cardiac injury","author":"Liu","year":"2020","journal-title":"MedRxiv"},{"issue":"1","key":"10.1016\/j.intimp.2020.107082_b0880","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12931-020-01352-w","article-title":"Prognostic value of NT-proBNP in patients with severe COVID-19","volume":"21","author":"Gao","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.intimp.2020.107082_b0885","first-page":"20029009","article-title":"Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China","author":"Huang","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.intimp.2020.107082_b0890","unstructured":"R. Qu, Y. Ling, Y.-h.-z. Zhang, L.-y. Wei, X. Chen, X.-m. Li, X.-y. Liu, H.-m. Liu, Z. Guo, H. Ren, Q. Wang, Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19, J. Med. Virol."},{"key":"10.1016\/j.intimp.2020.107082_b0895","first-page":"20026989","article-title":"The definition and risks of Cytokine Release Syndrome-Like in 11 COVID-19-Infected Pneumonia critically ill patients: disease characteristics and retrospective analysis","author":"Wang","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.intimp.2020.107082_b0900","first-page":"20051763","article-title":"Virologic and clinical characteristics for prognosis of severe COVID-19: a retrospective observational study in Wuhan, China","author":"Fu","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.intimp.2020.107082_b0905","first-page":"20035048","article-title":"Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19","author":"Zhang","year":"2020","journal-title":"MedRxiv"},{"issue":"5","key":"10.1016\/j.intimp.2020.107082_b0910","first-page":"411","article-title":"A pathological report of three COVID-19 cases by minimal invasive autopsies","volume":"49","author":"Yao","year":"2020","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"10223","key":"10.1016\/j.intimp.2020.107082_b0915","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.intimp.2020.107082_b0920","first-page":"20025643","article-title":"Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19 Pneumonia","author":"Gong","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.intimp.2020.107082_b0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.04.027","article-title":"Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19","author":"Yang","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2020.107082_b0930","doi-asserted-by":"crossref","first-page":"102763","DOI":"10.1016\/j.ebiom.2020.102763","article-title":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients","volume":"55","author":"Liu","year":"2020","journal-title":"EBioMedicine"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920328393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920328393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:23:21Z","timestamp":1761585801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920328393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":186,"alternative-id":["S1567576920328393"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107082","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107082"}}